I agree that this site is using cookies. You can find further informations here.
X
Schultze‐Mosgau, Marcus‐Hillert
28  results:
Search for persons X
?
1

Assessment of the CYP3A4 Induction Potential by Carbamazepi..:

Kanefendt, Friederike ; Dallmann, André ; Chen, Huijun...
Clinical Pharmacology & Therapeutics.  115 (2024)  5 - p. 1025-1032 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Assessment of the safe and efficacious dose of the selectiv..:

Sutter, Gabriele ; Frei, Matthias ; Schultze‐Mosgau, Marcus‐Hillert...
British Journal of Clinical Pharmacology.  88 (2021)  2 - p. 734-741 , 2021
Link: https://doi.org/10.1111/..
 
?
3

Effect of Food Intake on the Pharmacokinetics of the Select..:

Schultze‐Mosgau, Marcus‐Hillert ; Kaiser, Andreas ; Zollmann, Frank S.
Clinical Pharmacology in Drug Development.  10 (2020)  6 - p. 675-680 , 2020
Link: https://doi.org/10.1002/..
 
?
4

The effects of vilaprisan on the pharmacodynamics and pharm..:

Schultze‐Mosgau, Marcus‐Hillert ; Schütt, Barbara ; Draeger, Corinna...
British Journal of Clinical Pharmacology.  87 (2020)  3 - p. 925-936 , 2020
Link: https://doi.org/10.1111/..
 
?
5

Pharmacokinetics and Safety of the Novel Selective Progeste..:

Schultze‐Mosgau, Marcus‐Hillert ; Lasseter, Kenneth C. ; Marbury, Thomas..
The Journal of Clinical Pharmacology.  60 (2020)  8 - p. 1030-1038 , 2020
Link: https://doi.org/10.1002/..
 
?
6

Pharmacokinetics and Safety of the Selective Progesterone R..:

Liu, Hongzhong ; Jiang, Ji ; Chen, Zhaozhao...
Clinical Pharmacology in Drug Development.  10 (2020)  5 - p. 486-493 , 2020
Link: https://doi.org/10.1002/..
 
?
7

Effect of hepatic impairment on the pharmacokinetics of vil..:

Chattopadhyay, Niladri ; Riecke, Kai ; Ligges, Sandra...
British Journal of Clinical Pharmacology.  85 (2019)  9 - p. 2011-2021 , 2019
Link: https://doi.org/10.1111/..
 
?
8

Front Cover: Discovery of Vilaprisan (BAY 1002670): A Highl..:

Möller, Carsten ; Bone, Wilhelm ; Cleve, Arwed...
ChemMedChem.  13 (2018)  21 - p. 2250-2250 , 2018
Link: https://doi.org/10.1002/..
 
?
9

Discovery of Vilaprisan (BAY 1002670): A Highly Potent and ..:

Möller, Carsten ; Bone, Wilhelm ; Cleve, Arwed...
ChemMedChem.  13 (2018)  21 - p. 2271-2280 , 2018
Link: https://doi.org/10.1002/..
 
?
10

CYP3A4‐mediated effects of rifampicin on the pharmacokineti..:

Chattopadhyay, Niladri ; Kanacher, Tobias ; Casjens, Manuela...
British Journal of Clinical Pharmacology.  84 (2018)  12 - p. 2857-2866 , 2018
Link: https://doi.org/10.1111/..
 
?
11

The safety and pharmacokinetics of rapid iloprost aerosol d..:

Gessler, Tobias ; Ghofrani, Hossein‐Ardeschir ; Held, Matthias...
Pulmonary Circulation.  7 (2017)  2 - p. 505-513 , 2017
Link: https://doi.org/10.1177/..
 
?
12

Effect of the Novel Selective Progesterone Receptor Modulat..:

Schütt, Barbara ; Schultze‐Mosgau, Marcus‐Hillert ; Draeger, Corinna...
The Journal of Clinical Pharmacology.  58 (2017)  2 - p. 228-239 , 2017
Link: https://doi.org/10.1002/..
 
?
13

Model‐Based Dose Selection for Intravaginal Ring Formulatio..:

Reinecke, Isabel ; Schultze‐Mosgau, Marcus‐Hillert ; Nave, Rüdiger..
The Journal of Clinical Pharmacology.  57 (2016)  5 - p. 640-651 , 2016
Link: https://doi.org/10.1002/..
 
?
14

Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 R..:

Reif, Stefanie ; Schultze-Mosgau, Marcus-Hillert ; Engelen, Anna...
European Journal of Drug Metabolism and Pharmacokinetics.  49 (2023)  1 - p. 71-85 , 2023
Link: https://doi.org/10.1007/..
 
?
15

Single- and Multiple-Dose Pharmacokinetics and Safety of Vi..:

Schultze-Mosgau, Marcus-Hillert ; Matsuki, Shunji ; Okumura, Kazuhito.
European Journal of Drug Metabolism and Pharmacokinetics.  47 (2021)  1 - p. 49-56 , 2021
Link: https://doi.org/10.1007/..
 
1-15